Catalyst Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US14888U1016

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Patrick J Mcenany. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Patrick J Mcenany reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:CPRX / Catalyst Pharmaceuticals, Inc. Director 4,171,559
US:KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Director 122,750
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Patrick J Mcenany. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas CPRX / Catalyst Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CPRX / Catalyst Pharmaceuticals, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2020-09-30 CPRX MCENANY PATRICK J 15,000 2.9700 15,000 2.9700 44,550 268 6.05 46,200 103.70
2019-10-03 CPRX MCENANY PATRICK J 10,000 4.8900 10,000 4.8900 48,900
2019-06-11 CPRX MCENANY PATRICK J 25,000 3.2300 25,000 3.2300 80,750
2018-12-19 CPRX MCENANY PATRICK J 20,000 2.2400 20,000 2.2400 44,800
2018-04-03 CPRX MCENANY PATRICK J 20,000 2.2900 20,000 2.2900 45,800
2017-09-05 CPRX MCENANY PATRICK J 20,000 2.5780 20,000 2.5780 51,560
2016-06-14 CPRX MCENANY PATRICK J 105,300 0.6508 105,300 0.6508 68,529
2016-04-26 CPRX MCENANY PATRICK J 50,000 0.6486 50,000 0.6486 32,430
2015-12-28 CPRX MCENANY PATRICK J 25,000 2.3890 25,000 2.3890 59,725
2015-10-01 CPRX MCENANY PATRICK J 10,000 2.8100 10,000 2.8100 28,100
2015-04-27 CPRX MCENANY PATRICK J 5,000 3.7900 5,000 3.7900 18,950
2015-01-08 CPRX MCENANY PATRICK J 50,000 2.7950 50,000 2.7950 139,750
2014-05-21 CPRX MCENANY PATRICK J 25,000 1.8890 25,000 1.8890 47,225
2014-02-07 CPRX MCENANY PATRICK J 25,000 1.8200 25,000 1.8200 45,500
2013-10-21 CPRX MCENANY PATRICK J 50,000 1.5946 50,000 1.5946 79,730
2013-02-19 CPRX MCENANY PATRICK J 50,000 0.4600 50,000 0.4600 23,000
2012-12-17 CPRX MCENANY PATRICK J 100,000 0.4450 100,000 0.4450 44,500
2012-11-15 CPRX MCENANY PATRICK J 100,000 0.4201 100,000 0.4201 42,010
2012-07-03 CPRX MCENANY PATRICK J 700 0.5350 700 0.5350 374
2012-07-02 CPRX MCENANY PATRICK J 30,500 0.5383 30,500 0.5383 16,418
2012-05-30 CPRX MCENANY PATRICK J 10,000 0.5790 10,000 0.5790 5,790
2012-05-24 CPRX MCENANY PATRICK J 31,250 0.8000 31,250 0.8000 25,000
2012-02-14 CPRX MCENANY PATRICK J 1,600 1.1000 1,600 1.1000 1,760
2012-02-14 CPRX MCENANY PATRICK J 23,400 1.1500 23,400 1.1500 26,910

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades
Vendas Internas CPRX / Catalyst Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CPRX / Catalyst Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2025-06-09 CPRX MCENANY PATRICK J 171,748 26.1100 171,748 26.1100 4,484,340 108 19.1300 -1,198,801 -26.73
2025-06-06 CPRX MCENANY PATRICK J 28,252 25.9450 28,252 25.9450 732,998
2024-11-20 CPRX MCENANY PATRICK J 72,500 21.2900 72,500 21.2900 1,543,525
2024-11-19 CPRX MCENANY PATRICK J 98,345 21.1880 98,345 21.1880 2,083,734
2024-11-14 CPRX MCENANY PATRICK J 44,655 21.7520 44,655 21.7520 971,336
2024-11-13 CPRX MCENANY PATRICK J 92,500 22.9780 92,500 22.9780 2,125,465
2024-11-12 CPRX MCENANY PATRICK J 70,000 23.4210 70,000 23.4210 1,639,470
2024-11-12 CPRX MCENANY PATRICK J 192,000 23.2010 192,000 23.2010 4,454,592
2024-11-11 CPRX MCENANY PATRICK J 230,000 23.5480 230,000 23.5480 5,416,040
2023-05-15 CPRX MCENANY PATRICK J 26,151 13.2300 26,151 13.2300 345,978
2022-11-21 CPRX MCENANY PATRICK J 150,000 15.3320 150,000 15.3320 2,299,800
2022-11-18 CPRX MCENANY PATRICK J 350,000 15.6220 350,000 15.6220 5,467,700
2022-09-14 CPRX MCENANY PATRICK J 946,846 15.4140 946,846 15.4140 14,594,684
2022-09-13 CPRX MCENANY PATRICK J 80,765 15.3290 80,765 15.3290 1,238,047
2022-08-19 CPRX MCENANY PATRICK J 125,000 14.0994 125,000 14.0994 1,762,425
2022-08-18 CPRX MCENANY PATRICK J 25,000 13.9340 25,000 13.9340 348,350
2022-08-18 CPRX MCENANY PATRICK J 50,000 13.9300 50,000 13.9300 696,500
2022-08-18 CPRX MCENANY PATRICK J 50,000 13.9590 50,000 13.9590 697,950
2022-08-18 CPRX MCENANY PATRICK J 50,000 13.9510 50,000 13.9510 697,550
2021-08-23 CPRX MCENANY PATRICK J 82,617 5.6250 82,617 5.6250 464,721
2021-08-20 CPRX MCENANY PATRICK J 54,161 5.5180 54,161 5.5180 298,860
2021-08-13 CPRX MCENANY PATRICK J 31,186 6.1740 31,186 6.1740 192,542
2021-08-13 CPRX MCENANY PATRICK J 31,529 6.0745 31,529 6.0745 191,523

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades
Compras Internas KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CPRX / Catalyst Pharmaceuticals, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
Vendas Internas KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CPRX / Catalyst Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Patrick J Mcenany conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-12-30 2025-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -6,786 4,171,559 -0.16
2025-12-30 2025-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 26,334 4,178,345 0.63
2025-12-10 2025-12-08 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 3,534 4,152,011 0.09
2025-12-03 2025-12-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -45,000 4,148,477 -1.07
2025-12-03 2025-12-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -45,000 4,148,477 -1.07
2025-12-03 2025-12-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -45,000 4,193,477 -1.06
2025-11-24 2025-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 1,775 4,283,477 0.04
2025-06-10 2025-06-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
S - Sale -171,748 4,281,702 -3.86 26.11 -4,484,340 111,795,239
2025-06-10 2025-06-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
S - Sale -28,252 4,453,450 -0.63 25.94 -732,998 115,544,760
2024-12-11 2024-12-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 3,533 4,481,702 0.08
2024-11-21 2024-11-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -72,500 4,478,169 -1.59 21.29 -1,543,525 95,340,218
2024-11-21 2024-11-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 72,500 4,550,669 1.62 3.54 256,650 16,109,368
2024-11-21 2024-11-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -98,345 4,478,169 -2.15 21.19 -2,083,734 94,883,445
2024-11-21 2024-11-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 98,345 4,576,514 2.20 3.54 348,141 16,200,860
2024-11-15 2024-11-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -44,655 4,478,169 -0.99 21.75 -971,336 97,409,132
2024-11-15 2024-11-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 44,655 4,522,824 1.00 3.54 158,079 16,010,797
2024-11-15 2024-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -92,500 4,478,169 -2.02 22.98 -2,125,465 102,899,367
2024-11-15 2024-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 92,500 4,570,669 2.07 3.54 327,450 16,180,168
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -192,000 4,478,169 -4.11 23.20 -4,454,592 103,897,999
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 192,000 4,670,169 4.29 3.54 679,680 16,532,398
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -70,000 4,478,169 -1.54 23.42 -1,639,470 104,883,196
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 70,000 4,548,169 1.56 4.01 280,700 18,238,158
2024-11-13 2024-11-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -230,000 4,478,169 -4.89 23.55 -5,416,040 105,451,924
2024-11-13 2024-11-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 230,000 4,708,169 5.14 4.01 922,300 18,879,758
2024-08-26 2024-08-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
G - Gift -5,100 4,478,169 -0.11
2024-08-19 2024-08-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
G - Gift -45,000 4,483,269 -0.99
2024-01-31 2024-01-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 116,667 4,528,256 2.64
2024-01-31 2024-01-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 26,333 4,411,589 0.60
2024-01-03 2024-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 250,000 4,385,256 6.05 1.13 282,500 4,955,339
2023-12-29 2023-12-27 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -10,362 4,135,256 -0.25
2023-12-29 2023-12-27 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 26,333 4,145,618 0.64
2023-05-17 2023-05-16 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 173,849 4,119,285 4.41 0.79 137,341 3,254,235
2023-05-17 2023-05-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -26,151 3,945,436 -0.66 13.23 -345,978 52,198,118
2023-05-17 2023-05-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26,151 3,971,587 0.66 0.79 20,659 3,137,554
2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -14,204 3,945,436 -0.36
2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 58,333 3,959,640 1.50
2022-12-30 2022-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -10,000 3,901,307 -0.26
2022-12-30 2022-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -10,000 3,911,307 -0.26
2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -12,133 3,921,307 -0.31
2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 30,834 3,933,440 0.79
2022-11-22 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -150,000 3,902,606 -3.70 15.33 -2,299,800 59,834,755
2022-11-22 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 150,000 4,052,606 3.84 2.24 336,000 9,077,837
2022-11-22 2022-11-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -350,000 3,902,606 -8.23 15.62 -5,467,700 60,966,511
2022-11-22 2022-11-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 350,000 4,252,606 8.97 2.24 784,000 9,525,837
2022-09-15 2022-09-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -946,846 3,902,606 -19.52 15.41 -14,594,684 60,154,769
2022-09-15 2022-09-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -80,765 4,849,452 -1.64 15.33 -1,238,047 74,337,250
2022-08-19 2022-08-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -125,000 4,930,217 -2.47 14.10 -1,762,425 69,513,102
2022-08-19 2022-08-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 125,000 5,055,217 2.54 2.53 316,250 12,789,699
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -50,000 4,930,217 -1.00 13.95 -697,550 68,781,457
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 50,000 4,980,217 1.01 2.53 126,500 12,599,949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock,. par value $0.001 per share
M - Exercise 50,000 4,980,217 1.01 2.53 126,500 12,599,949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -50,000 4,930,217 -1.00 13.96 -697,950 68,820,899
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 50,000 4,980,217 1.01 2.53 126,500 12,599,949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -50,000 4,930,217 -1.00 13.93 -696,500 68,677,923
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -25,000 4,930,217 -0.50 13.93 -348,350 68,697,644
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 25,000 4,955,217 0.51 2.53 63,250 12,536,699
2022-02-16 2022-02-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 175,000 3,665,834 5.01
2021-12-30 2021-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 270,000 3,490,834 8.38
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -30,833 3,220,834 -0.95
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -12,132 4,930,227 -0.25
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 30,833 4,942,359 0.63
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -120,000 3,251,667 -3.56
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -82,617 4,911,526 -1.65 5.62 -464,721 27,627,334
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 120,000 4,994,143 2.46 3.12 374,400 15,581,726
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -80,000 3,371,667 -2.32
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -54,161 4,874,143 -1.10 5.52 -298,860 26,895,521
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 80,000 4,928,304 1.65 3.12 249,600 15,376,308
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -100,000 3,451,667 -2.82
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -31,529 4,848,304 -0.65 6.07 -191,523 29,451,023
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -31,186 4,879,833 -0.64 6.17 -192,542 30,128,089
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 100,000 4,911,019 2.08 3.12 312,000 15,322,379
2021-01-04 2020-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 400,000 3,551,667 12.69
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -30,833 3,151,667 -0.97
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -7,507 4,811,019 -0.16
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 30,833 4,818,526 0.64
2020-09-30 2020-09-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 15,000 4,787,693 0.31 2.97 44,550 14,219,448
2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 92,500 3,182,500 2.99
2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 740,000 3,090,000 31.49
2019-10-03 2019-10-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 10,000 4,772,693 0.21 4.89 48,900 23,338,469
2019-06-11 2019-06-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 25,000 4,762,693 0.53 3.23 80,750 15,383,498
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166,667 2,350,000 7.63
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166,667 2,350,000 7.63
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166,666 2,016,666 9.01
2018-12-19 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 20,000 4,737,693 0.42 2.24 44,800 10,612,432
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166,667 1,850,000 9.90
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166,667 1,850,000 9.90
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166,666 1,516,666 12.35
2018-04-03 2018-04-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 20,000 4,717,693 0.43 2.29 45,800 10,803,517
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 1,350,000 8.00
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 1,350,000 8.00
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 1,250,000 8.70
2017-11-14 2017-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -26,667 0 -100.00
2017-11-14 2017-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26,667 4,697,693 0.57
2017-11-07 2017-11-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -200,000 500,000 -28.57
2017-11-07 2017-11-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 200,000 4,671,026 4.47 0.47 94,000 2,195,382
2017-09-05 2017-09-05 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 20,000 4,471,026 0.45 2.58 51,560 11,526,305
2017-05-22 2017-05-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Warrants to Purchase Common Stock
X - Other -31,250 0 -100.00 0.80 -25,000
2017-05-22 2017-05-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 31,250 4,451,026 0.71 1.04 32,500 4,629,067
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 83,334 1,250,000 7.14
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 83,333 1,166,666 7.69
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 83,333 1,166,666 7.69
2016-11-18 2016-11-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -26,667 26,667 -50.00
2016-11-18 2016-11-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26,667 4,419,776 0.61
2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 1,100,000 10.00
2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 1,100,000 10.00
2016-06-14 2016-06-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 105,300 4,393,109 2.46 0.65 68,529 2,859,035
2016-04-26 2016-04-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 50,000 4,287,809 1.18 0.65 32,430 2,781,073
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 900,000 12.50
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 900,000 12.50
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100,000 800,000 14.29
2015-12-28 2015-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 25,000 4,237,809 0.59 2.39 59,725 10,124,126
2015-12-07 2015-12-07 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -26,666 53,334 -33.33
2015-12-07 2015-12-07 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26,666 4,212,809 0.64
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -75,000 600,000 -11.11
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
F - Taxes -26,119 4,186,143 -0.62
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 75,000 4,212,262 1.81 1.09 81,750 4,591,366
2015-10-01 2015-10-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 10,000 4,137,262 0.24 2.81 28,100 11,625,706
2015-04-27 2015-04-27 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
P - Purchase 5,000 4,127,262 0.12 3.79 18,950 15,642,323
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
M - Exercise -364,804 786,250 -31.69
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
F - Taxes -67,539 4,122,262 -1.61
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
M - Exercise 364,804 4,189,801 9.54 0.68 249,891 2,870,014
2015-01-08 2015-01-08 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
P - Purchase 50,000 3,970,918 1.28 2.80 139,750 11,098,716
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units
A - Award 26,667 1,151,054 2.37
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units
A - Award 26,667 1,151,054 2.37
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units
A - Award 26,666 1,097,720 2.49
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 100,000 1,221,054 8.92
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 100,000 1,121,054 9.79
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 100,000 1,021,054 10.86
2014-10-03 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
M - Exercise -150,000 1,231,054 -10.86
2014-10-03 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
M - Exercise 150,000 3,920,918 3.98 0.90 135,000 3,528,826
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 153,334 1,381,054 12.49
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 153,333 1,227,720 14.27
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 153,333 1,227,720 14.27
2014-07-02 2014-07-01 4 KOOL CESCA THERAPEUTICS INC.
Option
A - Award 25,000 122,750 25.58
2014-05-21 2014-05-21 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 25,000 3,656,247 0.69 1.89 47,225 6,906,651
2014-02-07 2014-02-07 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 25,000 3,631,247 0.69 1.82 45,500 6,608,870
2013-10-21 2013-10-21 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 50,000 3,606,247 1.41 1.59 79,730 5,750,521
2013-07-02 2013-07-01 4 KOOL THERMOGENESIS CORP
Option
A - Award 15,000 109,000 15.96
2013-02-20 2013-02-19 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 50,000 3,556,247 1.43 0.46 23,000 1,635,874
2012-12-18 2012-12-17 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 100,000 3,449,997 2.99 0.44 44,500 1,535,249
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 66,667 936,054 7.67
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 66,667 936,054 7.67
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 66,666 802,720 9.06
2012-11-15 2012-11-15 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 100,000 3,349,997 3.08 0.42 42,010 1,407,334
2012-07-05 2012-07-02 4 KOOL THERMOGENESIS CORP
Option
A - Award 15,000 100,500 17.54
2012-07-03 2012-07-03 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 700 3,249,997 0.02 0.54 374 1,738,748
2012-07-03 2012-07-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 30,500 3,249,297 0.95 0.54 16,418 1,749,097
2012-05-31 2012-05-30 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 10,000 3,218,797 0.31 0.58 5,790 1,863,683
2012-05-29 2012-05-24 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Warrants to Purchase Common Stock
P - Purchase 31,250 1,009,191 3.20
2012-05-29 2012-05-24 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 31,250 3,208,797 0.98 0.80 25,000 2,567,038
2012-02-14 2012-02-14 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 23,400 3,202,547 0.74 1.15 26,910 3,682,929
2012-02-14 2012-02-14 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 1,600 3,179,147 0.05 1.10 1,760 3,497,062
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)